KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Liabilities (2016 - 2026)

Eli Lilly filings provide 18 years of Total Liabilities readings, the most recent being $85.4 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities rose 14.93% to $85.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $85.4 billion, a 14.93% increase, with the full-year FY2025 number at $85.9 billion, up 5.96% from a year prior.
  • Total Liabilities hit $85.4 billion in Q1 2026 for Eli Lilly, down from $85.9 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $103.1 billion in Q2 2025 to a low of $49.5 billion in Q1 2022.
  • Median Total Liabilities over the past 5 years was $66.7 billion (2023), compared with a mean of $68.6 billion.
  • Biggest five-year swings in Total Liabilities: increased 0.18% in 2022 and later soared 43.4% in 2025.
  • Eli Lilly's Total Liabilities stood at $53.3 billion in 2022, then rose by 25.07% to $66.7 billion in 2023, then grew by 21.59% to $81.1 billion in 2024, then increased by 5.96% to $85.9 billion in 2025, then fell by 0.66% to $85.4 billion in 2026.
  • The last three reported values for Total Liabilities were $85.4 billion (Q1 2026), $85.9 billion (Q4 2025), and $91.1 billion (Q3 2025) per Business Quant data.